TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 3 | 6 | 6 | -13 | -13 | -4 | 559 | 90 |
| P | %wins | 100 | 67 | 33 | 33 | 33 | 50 | 53 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/20 14:45 | 11/10/20 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Clark William D | MA | DO | P,CEO | P | 10 | 2.06 | 0 | 5 | New | 5 | D | ||||||||||||||
1/19/18 15:21 | 1/17/18 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Clark William D | MA | DO | P,CEO | P | 20 | 0.8000 | 0 | 25 | 43 | 83 | D | |||||||||||||||
11/9/16 17:29 | 11/7/16 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Clark William D | MA | DO | P,CEO | P | 10 | 3.49 | 1 | 3 | 6 | 52 | D | -58 | -40 | -1 | -21 | -36 | -9 | 1 | 10 | 8 | 17 | 12 | 20 | 60 | ||
12/16/15 17:05 | 12/16/15 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Clark William D | MA | DO | P,CEO | P | 25 | 6.45 | 1 | 4 | 10 | 44 | D | -22 | -53 | -36 | 19 | 0 | -5 | -2 | 5 | -7 | -46 | -35 | -41 | -38 | ||
8/11/08 14:13 | 8/7/08 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Clark William D | MD | O | SVP,Chie | P | 50 | 0.9900 | 4 | 50 | New | 50 | D | -88 | -93 | -74 | -76 | -70 | -69 | 19 | 17 | 6 | 8 | -5 | -23 | -32 | 999 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |